摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methacryloyloxyethyl phenyl phosphate | 64716-34-3

中文名称
——
中文别名
——
英文名称
2-Methacryloyloxyethyl phenyl phosphate
英文别名
2-[hydroxy(phenoxy)phosphoryl]oxyethyl 2-methylprop-2-enoate
2-Methacryloyloxyethyl phenyl phosphate化学式
CAS
64716-34-3
化学式
C12H15O6P
mdl
——
分子量
286.22
InChiKey
LYRWNAXKUQELGU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    19
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    82.1
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • DENTAL POLYMERIZABLE MONOMER COMPOSITIONS
    申请人:MITSUI CHEMICALS, INC.
    公开号:US20170181932A1
    公开(公告)日:2017-06-29
    Provided are dental polymerizable monomer compositions that can give cured products having high toughness and high rigidity, and dental compositions containing such dental polymerizable monomer compositions and cured products thereof having high mechanical properties. The dental polymerizable monomer composition includes a urethane acrylate compound (A) and a polymerizable compound (B) having at least one polymerizable group selected from methacryloyl groups and acryloyl groups, the urethane acrylate compound (A) being obtained by reacting a specific hydroxyacrylate (a1) with a diisocyanate (a2) having two isocyanate groups bonded to a divalent C 6-9 aromatic hydrocarbon group or a divalent C 6-9 bridged cyclic hydrocarbon group via a methylene group optionally substituted with a hydrocarbon group in place of a hydrogen atom, the proportion of the number of acryloyl groups present in the urethane acrylate compound (A) being 10% to less than 90% relative to the total number of (meth)acryloyl groups in the monomer composition.
    提供了一种牙科可聚合单体组合物,可使固化产物具有高韧性和高刚度,并且含有这种牙科可聚合单体组合物和具有高机械性能的固化产物的牙科组合物。该牙科可聚合单体组合物包括一种丙烯酸酯化合物(A)和一种具有至少一种可聚合基团,所述可聚合基团选自甲基丙烯酰基团和丙烯酰基团的可聚合化合物(B),丙烯酸酯化合物(A)是通过将特定的羟基丙烯酸酯(a1)与具有两个异氰酸基团与一个二价C6-9芳香烃基或一个二价C6-9桥环烃基通过一个亚甲基团或者可选地替代氢原子的烃基的甲烷基团相结合的二异氰酸酯(a2)反应而得到的,相对于单体组合物中(甲)丙烯酰基团的总数,丙烯酸酯化合物(A)中存在的丙烯酰基团的比例为10%至90%。
  • DENTAL MATERIALS ON THE BASIS OF UREA GROUP-CONTAINING MONOMERS
    申请人:IVOCLAR VIVADENT AG
    公开号:US20160151249A1
    公开(公告)日:2016-06-02
    Dental material which contains a urea derivative according to general formula I, in which R 1 and R 2 are in each case independently of each other an aliphatic C 1 -C 15 radical which can be interrupted by —O—, —S—, —CO—O—; X is a radically polymerizable group; Y is a radically polymerizable group or an acid group; n, m are in each case independently of each other 1, 2, or 3.
    含有一种按照一般式I的生物的牙科材料,其中R1和R2分别为独立的脂肪族C1-C15基团,可以被—O—,—S—,—CO—O—打断;X是一个基团,可以被自由基聚合;Y是一个自由基聚合基团或酸基团;n,m分别独立地为1、2或3。
  • ACIDIC HYBRID MONOMERS AND DENTAL MATERIALS BASED THEREON
    申请人:Ivoclar Vivadent AG
    公开号:US20170281475A1
    公开(公告)日:2017-10-05
    Acidic monomer according to Formula I: in which A is a linear or branched aliphatic C 1 -C 18 -hydrocarbon group, which can be interrupted by one or more —O—, —S—, —CO—O—, —O—CO—NH—, —HN—CO—NH— or —CO—NR 1 —; R 1 is H or a C 1 -C 6 alkyl group; X is absent or is a linear or branched aliphatic C 1 -C 10 hydrocarbon group, which can be interrupted by one or more —O—, —S—, —CO—O—, —O—CO—NH—, —HN—CO—NH— or —CO—NR 2 —; R 2 is H or a C 1 -C 6 alkyl group; PG is a radically polymerizable group, preferably vinyl, allyl, CH 2 ═CR 3 —CO—Y— or R 4 O—CO—C(═CH 2 )—CH 2 —Y—; Y═O or NR 5 or is absent; R 3 is H or CH 3 ; R 4 is H or a C 1 -C 7 alkyl group; R 5 is H or a C 1 -C 7 alkyl group; n is 1, 2, 3 or 4; m=1 or 2; p=1, 2 or 3; and q=1, 2 or 3. The monomers are particularly suitable as components of dental material.
    根据公式I,酸性单体包括以下成分:其中A是线性或支链脂肪族C1-C18烃基,可以被一个或多个-O-,-S-,-CO-O-,-O-CO-NH-,-HN-CO-NH-或-CO-NR1-所中断;R1为H或C1-C6烷基;X不存在或是线性或支链脂肪族C1-C10烃基,可以被一个或多个-O-,-S-,-CO-O-,-O-CO-NH-,-HN-CO-NH-或-CO-NR2-所中断;R2为H或C1-C6烷基;PG是一个自由基聚合基团,优选为乙烯基,烯丙基,CH2═CR3—CO—Y—或R4O—CO—C(═ )— —Y—;Y为O或NR5或不存在;R3为H或CH3;R4为H或C1-C7烷基;R5为H或C1-C7烷基;n为1、2、3或4;m为1或2;p为1、2或3;q为1、2或3。这些单体特别适用于牙科材料的成分。
  • Photopolymerizable dental materials with bisacylphosphine oxides as initiators
    申请人:Moszner Norbert
    公开号:US20070027229A1
    公开(公告)日:2007-02-01
    Polymerizable dental material which contains at least one radically-polymerizable monomer and at least one bisacylphosphine oxide of the Formula I, in which R 1 is a linear or branched C 2 to C 14 alkyl residue, which can be interrupted by one or more O atoms, PG-Y-R 2 -X- or a substituted or unsubstituted, aromatic C 6 to C 14 radical; R 2 is absent or a linear or branched C 1 to C 20 alkylene radical, which can be interrupted by one or more O atoms; R 3 is H, a linear or branched C 1 to C 6 alkyl residue or PG-Y-R 2 -X-; R 4 is a linear or branched C 1 -C 6 alkyl or —O—C 1 -C 6 alkyl residue; R 5 is H or PG-Y-R 2 -X-; R 6 is H or PG-Y-R 2 -X-; PG is a polymerizable group; X is absent, O or S; Y is absent, O, S, an ester, amide or urethane group; the bisacylphosphine oxide having at least one PG-Y-R 2 -X group and X and/or Y being absent if R 2 is absent.
    这是一种聚合牙科材料,其中至少含有一种自由基聚合单体和至少一种公式I的双酰基氧化膦,其中R1是线性或支链的C2到C14烷基残基,可以被一个或多个O原子中断,也可以是PG-Y-R2-X-或取代或未取代的芳香族C6到C14基团;R2不存在或是线性或支链的C1到C20烷基残基,可以被一个或多个O原子中断;R3是H,线性或支链的C1到C6烷基残基或PG-Y-R2-X-;R4是线性或支链的C1-C6烷基或-O-C1-C6烷基残基;R5是H或PG-Y-R2-X-;R6是H或PG-Y-R2-X-;PG是可聚合的基团;X不存在、O或S;Y不存在、O、S、酯、酰胺或基团;如果R2不存在,则双酰基氧化膦至少具有一个PG-Y-R2-X基团,并且X和/或Y不存在。
  • B-Ketophosphonic Acids And Dental Materials Based Thereon
    申请人:IVOCLAR VIVADENT AG
    公开号:US20160145277A1
    公开(公告)日:2016-05-26
    β-Ketophosphonic acid according to general formula I: in which A=an aliphatic C 1 -C 18 radical which can be interrupted by —O—, —S—, —CO—O— or —O—CO—C—; n=1, 2, 3 or 4; m=1 or 2; X=absent or a C 1 -C 10 radical which can be interrupted by —O—, —S—, —CO—C—, —O—CO—NH— or —CO—NR 1 —, wherein R 1 is H or C 1 -C 7 -alkyl; and PG=a group which can undergo free radical polymerization. The β-ketophosphonic acids are suitable in particular for the preparation of dental materials.
    β-酮磷酸根据一般式I:其中A=一种脂肪族C1-C18基团,可以被—O—、—S—、—CO—O—或—O—CO—C—中断;n=1、2、3或4;m=1或2;X=不存在或是一种C1-C10基团,可以被—O—、—S—、—CO—C—、—O—CO—NH—或—CO—NR1—中断,其中R1为H或C1-C7-烷基;PG=可以发生自由基聚合的基团。β-酮磷酸特别适用于制备牙科材料。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫